AzTrials
AzTrials

Acute Hypoxemic Respiratory FailureNCT06936618

EIT-Guided Ventilator Settings in AHRF

A study testing Electrical Impedance Tomography (EIT), Enlight 2100 in people with Acute Hypoxemic Respiratory Failure and Acute Respiratory Distress Syndrome (ARDS), run by Mahidol University at 1 site in Thailand.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This exploratory study aims to investigate the effect of Electrical Impedance Tomography (EIT)-guided ventilator settings on mechanical power in patients with acute hypoxemic respiratory failure (AHRF), including both ARDS and non-ARDS conditions. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Electrical Impedance Tomography (EIT), Enlight 2100
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
17 participants
Where
1 siteThailand
Study dates
17 Dec 2024to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥ 18 years
  • Diagnosed with acute hypoxemic respiratory failure within 48 hours
  • Expected to require invasive mechanical ventilation ≥ 48 hours
  • On mechanical ventilation within 24 hours
  • Deep sedation and neuromuscular blockade

Who cannot join

  • Pregnancy
  • Body mass index (BMI) > 40 kg/m2
  • Contraindications to using electrical impedance tomography, including
  • Presence of a pacemaker or automatic implantable cardioverter-defibrillator (AICD)
  • Inability to place the belt due to presence of surgical wounds dressing, thoracic or spinal cord trauma, recent thoracic surgery, etc.
  • High risk for PEEP titration
Show all 17Show fewer
  • Hemodynamic instability defined as mean arterial pressure < 65 mmHg despite optimization of fluid status and/or use of vasopressors
  • Unstable cardiac arrhythmias
  • Presence of lung bullae greater than 2 cm in diameter, identified on chest X-ray
  • Presence of pneumothorax or pneumomediastinum
  • Right-sided heart failure or severe pulmonary hypertension
  • Neurologic conditions associated with a risk of intracranial hypertension
  • Use of extracorporeal membrane oxygenation (ECMO)
  • Severe chronic respiratory disease, defined as follows: requiring home oxygen therapy, or previous lung function showing (FEV1 less than 20 ml/kg PBW, or FEV1/FVC less than 50% predicted value), or chronic hypercapnia (PaCO2 greater than 45 mmHg) and/or chronic hypoxemia (PaO2 less than 55 mmHg) on FIO2 = 0.21, or radiographic x-ray evidence of any chronic over-inflation or chronic interstitial infiltration, or chronic restrictive, obstructive, neuromuscular, chest wall or pulmonary vascular disease resulting in severe exercise restriction (unable to climb stairs or perform household duties, secondary polycythemia, severe pulmonary hypertension with mean pulmonary arterial pressure greater than 40 mmHg)
  • Decision to withhold life-sustaining treatment or palliative care.
  • Moribund status with an expected survival of less than 24 hours.
  • Refusal to provide informed consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jitanong Sootlek, MD, PCCM contact

+66954164563

jitanong9651@gmail.com

Ranistha Ratanarat, MD, Nephrology, Critical care contact

+66896685287

ranittha@gmail.com

Thailand1 site, 1 recruiting
  • Siriraj Hospital, Mahidol University

    Bangkok, 10700

    Ranistha Ratanarat, MD, Nephrology, Critical care, +66896685287, ranittha@gmail.com

    Ranistha Ratanarat, MD, Nephrology, Critical care

    Recruiting

Other trials in Thailand

About this study

Official title: Using Electrical Impedance Tomography-Guided Ventilator Settings to Reduce Mechanical Power in Acute Hypoxemic Respiratory Failure : An Exploratory Study

This exploratory study aims to investigate the effect of Electrical Impedance Tomography (EIT)-guided ventilator settings on mechanical power in patients with acute hypoxemic respiratory failure (AHRF), including both ARDS and non-ARDS conditions. Mechanical power, a key factor associated with ventilator-induced lung injury (VILI), will be measured before and after EIT-guided PEEP titration. The study will evaluate feasibility and changes in lung mechanics, gas exchange, and EIT parameters. A total of 17 patients requiring invasive mechanical ventilation will be enrolled at Siriraj Hospital, Mahidol University.

Read the detailed description

This exploratory study investigates the effect of Electrical Impedance Tomography (EIT)-guided PEEP titration on mechanical power in patients with acute hypoxemic respiratory failure (AHRF), including both ARDS and non-ARDS conditions such as severe pneumonia and pulmonary edema. Mechanical power represents the energy transferred from the ventilator to the respiratory system per unit time and has been associated with the development of ventilator-induced lung injury (VILI).

Patients who meet the inclusion criteria will undergo a standardized EIT-guided PEEP titration protocol using the Enlight 2100 EIT device. Optimal PEEP is defined as the PEEP level that minimizes both alveolar overdistension and collapse based on real-time EIT measurements. Mechanical power and other ventilatory parameters (lung compliance, plateau pressure, driving pressure, 4∆P x RR index, and gas exchange) will be assessed before and after PEEP titration at predefined time points (baseline, 2, 12, and 24 hours).

The study also evaluates the regional ventilation distribution ratios, as well as safety outcomes including hemodynamic instability, arrhythmias, and pneumothorax. Patients will be followed for up to 28 days to record duration of mechanical ventilation, ICU stay, and 28-day mortality.

This study aims to assess the feasibility and physiological benefits of personalized ventilator settings using EIT in critically ill patients with AHRF and to generate preliminary data for future interventional studies.

Being tested
Electrical Impedance Tomography (EIT), Enlight 2100
Keywords
Acute Hypoxemic Respiratory Failure; Electrical Impedance Tomography; Mechanical Power, Ventilator-induced lung injury
Medical subject headings
Respiratory Insufficiency, Respiratory Distress Syndrome, Ventilator-Induced Lung Injury

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Electrical Impedance Tomography (EIT), Enlight 2100Device

    Patients will undergo ventilator adjustments using EIT-guided PEEP titration to optimize mechanical power and lung mechanics.

Study groups in NCT06936618
Study groupRoleWhat they receive
EIT-guided PEEP titrationExperimentalPatients will undergo ventilator adjustments using EIT-guided PEEP titration to optimize mechanical power and lung mechanics.
Receives: Device: Electrical Impedance Tomography (EIT), Enlight 2100

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Mechanical Power

    Mechanical power (MP) will be calculated using Gattinoni's simplified formula. Simplified Gattinoni's formula: MP = 0.098 × respiratory rate × tidal volume × [peak inspiratory pressure - (plateau pressure - PEEP)/2] calculated mechanical power (measured in J/min) before and after using EIT-guided PEEP titration in patients with acute hypoxemic respiratory failure.

    Unit of Measure: Joules per minute (J/min)

    Measured: ฺBaseline and 2 hours after EIT-guided ventilator adjustment and follow-up over 24 hours (baseline, 2 hours, 12 hours, and 24 hours after EIT-guided ventilator adjustment)

Secondary outcomes (14)
  1. Change in PEEP level

    Positive End-Expiratory Pressure (PEEP) level before and after EIT-guided ventilator adjustment.

    Unit of Measure: cmH₂O

    Measured: At baseline and then 2 hours, 12 hours, 24 hours after EIT-guided PEEP titration

  2. Change in Respiratory Static Compliance

    calculate static respiratory compliance (tidal volume/driving pressure) before and after EIT-guided PEEP titration Unit of Measure: mL/cmH₂O

    Measured: Baseline, 2 hours, 12 hours, and 24 hours after intervention

  3. Change in Driving Pressure

    calculate driving pressure (plateau pressure - PEEP) following EIT-guided PEEP titration.

    Unit of Measure: cmH₂O

    Measured: Baseline, 2 hours, 12 hours, and 24 hours after intervention

  4. Change in Plateau Pressure

    measure plateau pressure before and after EIT-guided PEEP titration.

    Measured: Baseline, 2 hours, 12 hours, and 24 hours after intervention

  5. Change in 4∆P + RR Index

    Calculated value of 4 x Driving Pressure + Respiratory Rate before and after EIT-guided PEEP titration.

    Unit of Measure: Joules per minute (J/min)

    Measured: Baseline, 2 hours, 12 hours, and 24 hours after intervention

  6. Change in Elastic dynamic power

    calculate elastic dynamic power formula : elastic dynamic power = 0.098 x respiratory rate x tidal volume x 0.5 x driving pressure before and following EIT-guided PEEP titration Unit of Measure: Joules per minute (J/min)

    Measured: Baseline, 2 hours, 12 hours, and 24 hours after intervention

  7. change in elastic static power

    calculated value of elastic static power = 0.098 x respiratory rate x tidal volume x PEEP before and after EIT-guided PEEP titration Unit of Measure: Joules per minute (J/min)

    Measured: Baseline, 2 hours, 12 hours, and 24 hours after intervention

  8. Change in resistive power

    calculated resistive power = 0.098 x respiratory rate x tidal volume x (peak inspiratory pressure - plateau pressure) before and after EIT-guided PEEP titration Unit of Measure: Joules per minute (J/min)

    Measured: Baseline, 2 hours, 12 hours, and 24 hours after intervention

  9. Change in arterial oxygen tension (PaO₂)

    Arterial oxygen tension (PaO₂) measured by arterial blood gas analysis before and after EIT-guided PEEP titration.

    Unit of Measure: PaO₂: mmHg

    Measured: Baseline, 2 hours, 12 hours, and 24 hours after intervention

  10. Ventilation distribution ratio

    record anterior/posterior and right/left ventilation distribution from EIT before and after EIT-guided PEEP titration Unit of Measure: Percentage (%)

    Measured: Baseline, 2 hours, 12 hours, and 24 hours after intervention

  11. Incidence of complication

    Number of patients experiencing adverse events related to EIT or ventilator adjustments, including pneumothorax, hemodynamic instability, or arrhythmia.

    Unit of Measure: Number of participants with event

    Measured: Up to 24 hours after intervention

  12. Change in arterial carbon dioxide tension (PaCO₂)

    Carbon dioxide tension (PaCO₂) measured by arterial blood gas analysis before and after EIT-guided PEEP titration.

    Unit of Measure: PaCO₂: mmHg

    Measured: Baseline, 2 hours, 12 hours, and 24 hours after intervention

  13. Change in arterial pH

    Arterial pH measured by arterial blood gas analysis before and after EIT-guided PEEP titration.

    Unit of Measure: pH: unitless

    Measured: Baseline, 2 hours, 12 hours, and 24 hours after intervention

  14. Change in PaO₂/FiO₂ ratio

    PaO₂/FiO₂ ratio changes before and after EIT-guided PEEP titration. PaO₂/FiO₂ ratio will be calculated using PaO₂ from arterial blood gas and FiO₂ obtained from ventilator settings.

    Unit of Measure: PaO₂/FiO₂: mmHg

    Measured: Baseline, 2 hours, 12 hours, and 24 hours after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Apr 2025
  2. Study start17 Dec 2024
  3. Primary completionOct 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
All enrolled patients will receive the intervention using EIT-guided PEEP titration. Outcomes such as mechanical power, lung mechanics, and gas exchange will be measured before and after the intervention in a single-arm, pre-post study design.
Masking
None (open label)
Enrolment
17 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06936618
Sponsor's protocol ID
SI 962/2024
Status last verified
Apr 2025
First submitted
26 Mar 2025
Last updated
27 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: This study does not plan to share individual participant data.

Questions about this trial

What is this clinical trial studying?

A study testing Electrical Impedance Tomography (EIT), Enlight 2100 in people with Acute Hypoxemic Respiratory Failure and Acute Respiratory Distress Syndrome (ARDS), run by Mahidol University at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jitanong Sootlek, MD, PCCM (+66954164563, jitanong9651@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Mechanical Power (time frame: ฺBaseline and 2 hours after EIT-guided ventilator adjustment and follow-up over 24 hours (baseline, 2 hours, 12 hours, and 24 hours after EIT-guided ventilator adjustment)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in